UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 157

Sortiert nach

Randomized Placebo-Controlled Clinical Trial of Dutasteride for Reducing Heavy Drinking in Men

Journal of clinical psychopharmacology, 2024-05, Vol.44 (3), p.223

2024

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and safety of a fixed‐dose combination of dutasteride and tamsulosin treatment (Duodart®) compared with watchful waiting with initiation of tamsulosin therapy if symptoms do not improve, both provided with lifestyle advice, in the management of treatment‐naïve men with moderately symptomatic benign prostatic hyperplasia: 2‐year CONDUCT study results

BJU international, 2015-09, Vol.116 (3), p.450-459

2015

Link zum Volltext

Verfügbarkeit prüfen

Dutasteride in localised prostate cancer management: the REDEEM randomised, double-blind, placebo-controlled trial

The Lancet (British edition), 2012-03, Vol.379 (9821), p.1103-1111

2012

Link zum Volltext

Verfügbarkeit prüfen

The Effects of Dutasteride, Tamsulosin and Combination Therapy on Lower Urinary Tract Symptoms in Men With Benign Prostatic Hyperplasia and Prostatic Enlargement: 2-Year Results From the CombAT Study

The Journal of urology, 2008-02, Vol.179 (2), p.616-621

2008

Link zum Volltext

Verfügbarkeit prüfen

Efficacy, safety, and tolerability of dutasteride 0.5 mg once daily in male patients with male pattern hair loss: A randomized, double-blind, placebo-controlled, phase III study

Journal of the American Academy of Dermatology, 2010-08, Vol.63 (2), p.252-258

2010

Link zum Volltext

Verfügbarkeit prüfen

Targeted Androgen Pathway Suppression in Localized Prostate Cancer: A Pilot Study

Journal of clinical oncology, 2014-01, Vol.32 (3), p.229-237

2014

Link zum Volltext

Verfügbarkeit prüfen

phase IIA randomized, placebo-controlled clinical trial to study the efficacy and safety of the selective androgen receptor modulator (SARM), MK-0773 in female participants with sarcopenia

The Journal of nutrition, health & aging, 2013, Vol.17 (6), p.533-543

2013

Link zum Volltext

Verfügbarkeit prüfen

Short‐term pretreatment with a dual 5α‐reductase inhibitor before bipolar transurethral resection of the prostate (B‐TURP): evaluation of prostate vascularity and decreased surgical blood loss in large prostates

BJU international, 2015-07, Vol.116 (1), p.117-123

2015

Link zum Volltext

Verfügbarkeit prüfen

Influence of baseline variables on changes in International Prostate Symptom Score after combined therapy with dutasteride plus tamsulosin or either monotherapy in patients with benign prostatic hyperplasia and lower urinary tract symptoms: 4‐year results of the CombAT study

BJU international, 2014-04, Vol.113 (4), p.623-635

2014

Link zum Volltext

Verfügbarkeit prüfen

Baseline characteristics predict risk of progression and response to combined medical therapy for benign prostatic hyperplasia (BPH)

BJU international, 2015-02, Vol.115 (2), p.308-318

2015

Link zum Volltext

Verfügbarkeit prüfen

Phase II Study of Androgen Synthesis Inhibition with Ketoconazole, Hydrocortisone, and Dutasteride in Asymptomatic Castration-Resistant Prostate Cancer

Clinical cancer research, 2009-11, Vol.15 (22), p.7099-7105

2009

Link zum Volltext

Verfügbarkeit prüfen

Improved Supersaturation and Oral Absorption of Dutasteride by Amorphous Solid Dispersions

Chemical and Pharmaceutical Bulletin, 2012/11/01, Vol.60(11), pp.1468-1473

2012

Link zum Volltext

Verfügbarkeit prüfen

Frontal fibrosing alopecia: treatment with oral dutasteride and topical pimecrolimus

Journal of the European Academy of Dermatology and Venereology, 2009-05, Vol.23 (5), p.580-582

2009

Link zum Volltext

Verfügbarkeit prüfen

Quality by design: screening of critical variables and formulation optimization of Eudragit E nanoparticles containing dutasteride

Archives of Pharmacal Research, 2013, 36(5), , pp.593-601

2013

Link zum Volltext

Verfügbarkeit prüfen

The Effects of Chronic 5‐Alpha‐Reductase Inhibitor (Dutasteride) Treatment on Rat Erectile Function

Journal of sexual medicine, 2011-11, Vol.8 (11), p.3066-3074

2011

Link zum Volltext

Verfügbarkeit prüfen

5α-Reductase inhibitors in androgenetic alopecia

Current opinion in endocrinology, diabetes, and obesity, 2014-12, Vol.21 (6), p.493-498

2014

Link zum Volltext

Verfügbarkeit prüfen

Controlled release of dutasteride from biodegradable microspheres: in vitro and in vivo studies

PloS one, 2014-12, Vol.9 (12), p.e114835

2014

Link zum Volltext

Verfügbarkeit prüfen

Contrast Enhanced Transrectal Ultrasound for the Detection of Prostate Cancer: A Randomized, Double-Blind Trial of Dutasteride Pretreatment

The Journal of urology, 2012-11, Vol.188 (5), p.1739-1745

2012

Link zum Volltext

Verfügbarkeit prüfen

Testosterone with Dutasteride, but Not Anastrazole, Improves Insulin Sensitivity in Young Obese Men: A Randomized Controlled Trial

Journal of sexual medicine, 2014-02, Vol.11 (2), p.563-573

2014

Link zum Volltext

Verfügbarkeit prüfen

Effect of dutasteride on clinical progression of benign prostatic hyperplasia in asymptomatic men with enlarged prostate: a post hoc analysis of the REDUCE study

BMJ (Online), 2013-04, Vol.346 (7908), p.f2109

International edition, 2013

Link zum Volltext

Verfügbarkeit prüfen

Dutasteride Treatment Over 2 Years Delays Prostate-specific Antigen Progression in Patients with Biochemical Failure After Radical Therapy for Prostate Cancer: Results from the Randomised, Placebo-controlled Avodart After Radical Therapy for Prostate Cancer Study (ARTS)

European urology, 2013-05, Vol.63 (5), p.779-787

2013

Link zum Volltext

Verfügbarkeit prüfen

Progression of Lower Urinary Tract Symptoms After Discontinuation of 1 Medication From 2-Year Combined Alpha-blocker and 5-Alpha–reductase Inhibitor Therapy for Benign Prostatic Hyperplasia in Men – A Randomized Multicenter Study

Urology (Ridgewood, N.J.), 2014-02, Vol.83 (2), p.416-421

2014

Link zum Volltext

Verfügbarkeit prüfen

Quantifying the Contribution of Symptom Improvement to Satisfaction of Men With Moderate to Severe Benign Prostatic Hyperplasia: 4-Year Data From the CombAT Trial

The Journal of urology, 2012-05, Vol.187 (5), p.1732-1738

2012

Link zum Volltext

Verfügbarkeit prüfen

Usefulness of prostate‐specific antigen (PSA) rise as a marker of prostate cancer in men treated with dutasteride: lessons from the REDUCE study

BJU international, 2012-04, Vol.109 (8), p.1162-1169

2012

Link zum Volltext

Verfügbarkeit prüfen

Transurethral resection of prostate and the role of pharmacological treatment with dutasteride in decreasing surgical blood loss

Journal of endourology, 2013-01, Vol.27 (1), p.68

2013

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 157

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(139)
Mit Volltextzugriff
(112)

Publikationsform

Artikel
(157)

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Male
(146)
Humans
(132)
Dutasteride
(125)
Azasteroids - Administration & Dosage
(119)
Science & Technology
(111)
Life Sciences & Biomedicine
(109)
Middle Aged
(70)
Prostatic Hyperplasia - Drug Therapy
(63)
Aged
(59)
Azasteroids - Therapeutic Use
(57)
Biological And Medical Sciences
(50)
Medical Sciences
(48)
5-Alpha Reductase Inhibitors
(47)
5-Alpha Reductase Inhibitors - Administration & Dosage
(45)
Treatment Outcome
(45)
Urology & Nephrology
(44)
Double-Blind Method
(40)
Azasteroids - Pharmacology
(33)
Dose-Response Relationship, Drug
(32)
Animals
(31)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Randomized Placebo-Controlled Clinical Trial of Dutasteride for Reducing Heavy Drinking in Men

Dutasteride in localised prostate cancer management: the REDEEM randomised, double-blind, placebo-controlled trial

The Effects of Dutasteride, Tamsulosin and Combination Therapy on Lower Urinary Tract Symptoms in Men With Benign Prostatic Hyperplasia and Prostatic Enlargement: 2-Year Results From the CombAT Study

Efficacy, safety, and tolerability of dutasteride 0.5 mg once daily in male patients with male pattern hair loss: A randomized, double-blind, placebo-controlled, phase III study

Targeted Androgen Pathway Suppression in Localized Prostate Cancer: A Pilot Study

phase IIA randomized, placebo-controlled clinical trial to study the efficacy and safety of the selective androgen receptor modulator (SARM), MK-0773 in female participants with sarcopenia

Short‐term pretreatment with a dual 5α‐reductase inhibitor before bipolar transurethral resection of the prostate (B‐TURP): evaluation of prostate vascularity and decreased surgical blood loss in large prostates

Influence of baseline variables on changes in International Prostate Symptom Score after combined therapy with dutasteride plus tamsulosin or either monotherapy in patients with benign prostatic hyperplasia and lower urinary tract symptoms: 4‐year results of the CombAT study

Baseline characteristics predict risk of progression and response to combined medical therapy for benign prostatic hyperplasia (BPH)

Phase II Study of Androgen Synthesis Inhibition with Ketoconazole, Hydrocortisone, and Dutasteride in Asymptomatic Castration-Resistant Prostate Cancer

Improved Supersaturation and Oral Absorption of Dutasteride by Amorphous Solid Dispersions

Frontal fibrosing alopecia: treatment with oral dutasteride and topical pimecrolimus

Quality by design: screening of critical variables and formulation optimization of Eudragit E nanoparticles containing dutasteride

The Effects of Chronic 5‐Alpha‐Reductase Inhibitor (Dutasteride) Treatment on Rat Erectile Function

5α-Reductase inhibitors in androgenetic alopecia

Controlled release of dutasteride from biodegradable microspheres: in vitro and in vivo studies

Contrast Enhanced Transrectal Ultrasound for the Detection of Prostate Cancer: A Randomized, Double-Blind Trial of Dutasteride Pretreatment

Testosterone with Dutasteride, but Not Anastrazole, Improves Insulin Sensitivity in Young Obese Men: A Randomized Controlled Trial

Effect of dutasteride on clinical progression of benign prostatic hyperplasia in asymptomatic men with enlarged prostate: a post hoc analysis of the REDUCE study

Dutasteride Treatment Over 2 Years Delays Prostate-specific Antigen Progression in Patients with Biochemical Failure After Radical Therapy for Prostate Cancer: Results from the Randomised, Placebo-controlled Avodart After Radical Therapy for Prostate Cancer Study (ARTS)

Progression of Lower Urinary Tract Symptoms After Discontinuation of 1 Medication From 2-Year Combined Alpha-blocker and 5-Alpha–reductase Inhibitor Therapy for Benign Prostatic Hyperplasia in Men – A Randomized Multicenter Study

Quantifying the Contribution of Symptom Improvement to Satisfaction of Men With Moderate to Severe Benign Prostatic Hyperplasia: 4-Year Data From the CombAT Trial

Usefulness of prostate‐specific antigen (PSA) rise as a marker of prostate cancer in men treated with dutasteride: lessons from the REDUCE study

Transurethral resection of prostate and the role of pharmacological treatment with dutasteride in decreasing surgical blood loss

Suchergebnisse filtern